Rubius Therapeutics Inc (NASDAQ:RUBY)
| 0.2804 Delayed Data As of Feb 03 |  -0.0135 / -4.59%Today’s Change | 0.14 Today|||52-Week Range 6.54 | +60.23% Year-to-Date |
Latest RUBY News | Press Releases
No recent news for Rubius Therapeutics Inc.
Today’s Trading
| Previous close | 0.29 |
| Today’s open | 0.29 |
| Day’s range | 0.28 - 0.31 |
| Volume | 21,075 |
| Average volume (3 months) | 1,169,502 |
| Market cap | $26.6M |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -7.42% |
| Earnings growth (this year) | +19.28% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.15 |
Competitors
Data as of 3:59pm ET, 02/03/2023
Financials
| Last reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$196.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
